Inappropriate Outpatient Antibiotic Rx Common for Children

THURSDAY, May 26, 2022 (HealthDay News) -- Inappropriate antibiotic prescriptions are common among children with common infections treated in an outpatient setting, according to a study published online May 26 in JAMA Network Open.
Anne M. Butler, Ph.D., from the Washington University School of Medicine in St. Louis, and colleagues conducted a cohort study involving children aged 6 months to 17 years diagnosed with a bacterial or viral infection as an outpatient from April 1, 2016, to Sept. 30, 2018, to examine the comparative safety and health care expenditures of inappropriate versus appropriate oral antibiotic prescriptions. Data were included for 2,804,245 eligible children.
The researchers found that 31 to 36 percent and 4 to 70 percent of the children received inappropriate antibiotics for bacterial infections and for viral infections, respectively. Among children treated with a nonrecommended antibiotic agent for a bacterial infection, inappropriate antibiotics were associated with an increased risk for several adverse drug events, including Clostridioides difficile infection and severe allergic reaction (hazard ratios, 6.23 and 4.14, respectively, among patients with suppurative otitis media [OM]). Among children who received inappropriate antibiotics, 30-day attributable health care expenditures were generally higher, ranging from $21 to $56 and from −$96 to $97 for bacterial and viral infections, respectively.
"This study continues to show that we have to do a better job of making sure antibiotics are used appropriately in all health care settings," a coauthor said in a statement. "Our failure to do so has real costs, both to the health of children and to our collective wallet."
Several authors disclosed financial ties to the pharmaceutical industry; one author has served as an expert witness.
Related Posts
Vinculan tres muertes con batidos contaminados con listeria de un restaurante en el estado de Washington
MARTES, 22 de agosto de 2023 (HealthDay News) -- Una cepa de la bacteria...
FDA Approves First Pill to Treat Severe Alopecia
TUESDAY, June 14, 2022 (HealthDay News) -- The first pill to treat adults with...
Health Highlights: Dec. 13, 2021
First real-world studies into vaccine effectiveness against Omicron. The ability...
ACP Issues Two Guidelines for Acute Left-Sided Colonic Diverticulitis
TUESDAY, Jan. 18, 2022 (HealthDay News) -- Two sets of guidelines have been...